AI cancer screening programs are booming, but you’ll likely have to pay for them yourself

CNBC May 30, 2024
Bertha Coombs

Key Points

– The FDA has approved nearly 600 radiology artificial intelligence and machine learning programs and devices over the last five years, but most aren’t covered by insurance.

– Medical associations and regulators are taking a cautious approach to designating new programs for reimbursement.

– Startup Avenda Health has received a provisional code for its prostate cancer screening, but its CEO worries the slow path to insurance reimbursement will impede adoption of the technology

– Without a billing code, radiology provider RadNet charges patients a cash fee to access its AI-enhanced breast cancer screening program

Artificial intelligence for cancer screening has taken off.

Yet most of those new programs aren’t covered by Medicare or private insurers, which creates headwinds...

Today's Sponsors

Today's Sponsor